Results from 2 randomized, double-blind, placebo-controlled studies of the novel nk1 receptor antagonist casopitant in patients with major depressive disorder

• Main Authors: Ratti, E., Bellew, K., Bettica, P., Bryson, H., Zamuner, S., Archer, G., Squassante, L., Bye, A., Trist, D., Krishnan, K.R., Fernandes, S.
• Other Authors: DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
• Format: Article
• Published: 2014
• Subjects: casopitant; depression; GW679769; NK 1 antagonist; receptor occupancy; sleep
• Online Access: http://scholarbank.nus.edu.sg/handle/10635/110626
• Institution: National University of Singapore

10.1097/JCP.0b013e31823608ca